The process begins with the synthesis of superparamagnetic nanoparticles, typically composed of iron oxide. These nanoparticles are then coated with specific ligands or antibodies to bind to target cells or tissues. When an external magnetic field is applied, the magnetic nanoparticles migrate towards the desired location, enhancing the concentration of the therapeutic agent at the target site while minimizing systemic distribution.
